Hoth Therapeutics

Recent Finacing

Series A

Recent Raise

$3M

Hoth Therapeutics is a development-stage biopharmaceutical company developing targeted therapeutics for dermatological indications, including atopic dermatitis, using its BioLexa targeted delivery platform.

Founded 2017

New York, United States

1-10

Publicly Traded

hoththerapeutics.com

Highlights

Focus Areas

Biotechnology

Health Care

Hospital

Medical

Financials

$3M

Total Raised

1

Funding round

Team

Upgrade to view the team

See the team members at Hoth Therapeutics.